Jan 3, 2023 Newark Beth Israel Medical Center Appoints New Medical Director of Heart Transplant and Mechanical Circulatory Support

Claudia G. Gidea, MD, FACCNewark, NJ, (January 3, 2023) – Claudia G. Gidea, MD, FACC, has been appointed Medical Director of Heart Transplant, Mechanical Circulatory Support, and Advanced Heart Failure at Newark Beth Israel Medical Center.

An accomplished clinician, Dr. Gidea brings more than 20 years of research, innovation, and clinical expertise to the Advanced Heart Failure Treatment and Transplant team at Newark Beth Israel Medical Center. She has published extensively in the field of heart transplantation and has been a regional leader in establishing programs to increase the availability of organs for donation and allow patients to get transplanted sooner.

“Dr. Gidea has a proven track record of delivering excellent care to our advanced heart failure patients and we are excited to welcome her back to the team,” said Sergio Waxman, MD, MBA, Director of Cardiology, Newark Beth Israel Medical Center.

“Our Advanced Heart Failure Treatment and Transplant team is at the forefront of delivering comprehensive care and advanced treatment options to our heart failure patients. Dr. Gidea is a seasoned professional who brings a wealth of experience to this expanded role and we are proud to welcome her back to Newark Beth Israel Medical Center,” said Darrell K. Terry, Sr., MHA, MPH, FACHE, FHELA President and Chief Executive Officer Newark Beth Israel Medical Center and Children’s Hospital of New Jersey.

Dr. Gidea is returning to Newark Beth Israel Medical Center after serving as Medical Director of the Heart Transplant and LVAD Program at Icahn School of Medicine at Mount Sinai in New York. Prior to that she was the Medical Director of the Cardiogenic Shock Program at NYU School of Medicine. She was the former Medical Director of Mechanical Circulatory Support at Newark Beth Israel Medical Center.

She received her medical degree from Carol Davila University of Medicine and Pharmacy, Faculty of Medicine, Bucharest, Romania, and her internship in Internal Medicine and Cardiology at the Emergency Clinical Hospital in Bucharest. She completed her cardiology fellowship at University of Wisconsin Hospital and Clinics, Michael Reese Hospital, where she received training in Advanced Heart Failure and Heart Transplant.

Dr. Gidea is a member of the International Society of Heart and Lung Transplantation, the Heart Failure Society of America, the American Society of Echocardiography, the American College of Cardiology and the American Heart Association.

For more information visit Newark Beth Israel’s Frederick B. Cohen Comprehensive Cancer and Blood Disorders Center.

About Newark Beth Israel Medical Center

Newark Beth Israel Medical Center, an RWJBarnabas Health facility, is a 665-bed regional care teaching hospital that provides comprehensive health care. Newark Beth Israel is a Top Teaching Hospital and home to one of the nation’s top 15 heart transplant centers, which has performed more than 1,100 heart transplants; RWJBarnabas Health’s Heart Failure Treatment and Transplant Program; New Jersey’s only Advanced Lung Disease and Transplant Program and a Valve Center that performs complex cardiac valve procedures, including minimally invasive transcatheter aortic valve replacements (TAVRs). Newark Beth Israel Medical Center is also home to Children’s Hospital of New Jersey (CHoNJ), which cares for children from birth through adolescence, with more than 30 specialized pediatric services including New Jersey’s largest Valerie Fund Children’s Center for Cancer and Blood Disorders; and the Children’s Heart Center that offers a complete range of medical and surgical treatments for the most complex cardiac abnormalities. The Newark Beth Israel robotic surgery program is the most experienced in northern New Jersey. RWJBarnabas Health and The Frederick B. Cohen, MD, Comprehensive Cancer and Blood Disorders Center at Newark Beth Israel Medical Center and the Healthcare Foundation of New Jersey Breast Health Center, in partnership with Rutgers Cancer Institute of New Jersey – the state's only NCI-designated Comprehensive Cancer Center – brings a world class team of researchers and specialists to fight alongside you, providing close-to-home access to the latest treatment and clinical trials. Newark Beth Israel also offers many preventive health programs that promote wellness in the community, including The Beth Greenhouse, which provides access to fresh produce and health and wellness education to local residents.

Children’s Hospital of New Jersey (CHoNJ), located at Newark Beth Israel Medical Center, cares for children from birth through adolescence, with more than 30 specialized pediatric services including New Jersey’s largest Valerie Fund Children’s Center for Cancer and Blood Disorders; and the Children’s Heart Center that offers a complete range of medical and surgical treatments for the most complex cardiac abnormalities. Children’s Hospital of New Jersey also includes a Neonatal Intensive Care Unit and a Level IV Regional Perinatal Center that offers New Jersey’s only Extracorporeal Membrane Oxygenation (ECMO) therapy; and the highest level of intensive care for both mothers and newborns.

Media Contact:
Linda Kamateh
973-926-7531
linda.kamateh@rwjbh.org